| For: | Franceschini A, Adinolfi E. P2X receptors: New players in cancer pain. World J Biol Chem 2014; 5(4): 429-436 [PMID: 25426266 DOI: 10.4331/wjbc.v5.i4.429] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v5/i4/429.htm |
| Number | Citing Articles |
| 1 |
Wen-Jun Zhang, Dingyi Chen. Mesenchymal stem cell transplantation plays a role in relieving cancer pain. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1483716
|
| 2 |
Geoffrey Burnstock. Pharmacological Mechanisms and the Modulation of Pain. Advances in Pharmacology 2016; 75 doi: 10.1016/bs.apha.2015.09.001
|
| 3 |
Ping-Fang Chen, Xue-Fei Ma, Liang-Fei Sun, Yun Tian, Ying-Zhe Fan, Peiwang Li, Zhihong Xiao, Michael X. Zhu, Chang-Run Guo, Changzhu Li, Ye Yu, Jin Wang. A conserved residue in the P2X4 receptor has a nonconserved function in ATP recognition. Journal of Biological Chemistry 2021; 296 doi: 10.1016/j.jbc.2021.100655
|
| 4 |
Songqiang Huang, Bo Peng, Wanting Dong, Jiapeng He, Hanbin Chen, Jin-Song Bian.
Na
+
/K
+
-ATPase Modulates Purinergic P2X3 Receptor Function to Drive Bone Cancer Pain
. Research 2025; 8 doi: 10.34133/research.0932
|
| 5 |
Wen-jun Zhang, Hong-liang Luo, Zheng-ming Zhu. The role of P2X4 receptors in chronic pain: A potential pharmacological target. Biomedicine & Pharmacotherapy 2020; 129 doi: 10.1016/j.biopha.2020.110447
|
| 6 |
Yong-sheng Xu, Jun Xiang, Si-jian Lin. Functional role of P2X7 purinergic receptor in cancer and cancer-related pain. Purinergic Signalling 2025; 21(4) doi: 10.1007/s11302-024-10019-w
|
| 7 |
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, Ali El-Tayeb, Josef Messinger, Aliaa Abdelrahman, Christiane Bous, Anke C. Schiedel, Christa E. Müller. Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist. Purinergic Signalling 2024; 20(6) doi: 10.1007/s11302-024-10005-2
|
| 8 |
Huiqin Zhu, Yi Yu, Lingyan Zheng, Lu Wang, Chenli Li, Jiangyuan Yu, Jing Wei, Chuang Wang, Junfang Zhang, Shujun Xu, Xiaofei Wei, Wei Cui, Qinwen Wang, Xiaowei Chen. Chronic inflammatory pain upregulates expression of P2Y2 receptor in small-diameter sensory neurons. Metabolic Brain Disease 2015; 30(6) doi: 10.1007/s11011-015-9695-8
|
| 9 |
Song Cao, Zhi Xiao, Mengjie Sun, Youyan Li. D-serine in the midbrain periaqueductal gray contributes to morphine tolerance in rats. Molecular Pain 2016; 12 doi: 10.1177/1744806916646786
|
| 10 |
Abeer F. Alharbi, John Parrington. The role of genetic polymorphisms in endolysosomal ion channels TPC2 and P2RX4 in cancer pathogenesis, prognosis, and diagnosis: a genetic association in the UK Biobank. npj Genomic Medicine 2021; 6(1) doi: 10.1038/s41525-021-00221-9
|
| 11 |
Abeer F. Alharbi, John Parrington. Endolysosomal Ca2+ Signaling in Cancer: The Role of TPC2, From Tumorigenesis to Metastasis. Frontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00302
|
| 12 |
Yehong Huo, Linhao Ma, Mengzhi Zhang, Mingcong Niu, Xiulian Gu, Wenjie Zhang, Miaomiao Yan, Guangcheng Wei. Development of anticancer peptides with low hemolysis, high penetrating membrane activity, certain analgesic activity and the synergistic anticancer effect. Biomaterials Science 2022; 10(7) doi: 10.1039/D1BM02024B
|
| 13 |
Pradeep Kumar Yadalam, Prabhu Manickam Natarajan, Seyed Ali Mosaddad, Artak Heboyan. Graph neural networks-based prediction of drug gene association of P2X receptors in periodontal pain. Journal of Oral Biology and Craniofacial Research 2024; 14(3) doi: 10.1016/j.jobcr.2024.04.008
|
| 14 |
Jia-Qi Hu, Xiao-Die Zhou, Qing-Ling Ren, Yue Han. Purinergic signaling and cancer neuroscience. Neuropharmacology 2026; 298 doi: 10.1016/j.neuropharm.2026.111048
|
| 15 |
Luke Tattersall, Dan C Gagui, Victoria L Tippett, Norain B Ab Latif, Karan M Shah, Alison Gartland. A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone Cancer. Frontiers in Bioscience-Landmark 2022; 27(4) doi: 10.31083/j.fbl2704122
|
| 16 |
Jinghao Wen, Zehao Lan, Liting He, Hai Long. Aberrant Activation of Mast Cells: Molecular Mechanisms and Targets for Intervention. Clinical Reviews in Allergy & Immunology 2025; 68(1) doi: 10.1007/s12016-025-09065-y
|
| 17 |
Aliaa Abdelrahman, Vigneshwaran Namasivayam, Sonja Hinz, Anke C. Schiedel, Meryem Köse, Maggi Burton, Ali El-Tayeb, Michel Gillard, Jürgen Bajorath, Marc de Ryck, Christa E. Müller. Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies. Biochemical Pharmacology 2017; 125 doi: 10.1016/j.bcp.2016.11.016
|
| 18 |
Zhi Xiao, You-Yan Li, Meng-Jie Sun. Activation of P2X7 receptors in the midbrain periaqueductal gray of rats facilitates morphine tolerance. Pharmacology Biochemistry and Behavior 2015; 135 doi: 10.1016/j.pbb.2015.06.002
|
| 19 |
Ying-lei Yu, Wei Xu, Si-hui Xie, Ri-xin Chen, Tao Yang. P2X2/3 receptors as a potential target for cancer pain treatment. Behavioural Brain Research 2026; 506 doi: 10.1016/j.bbr.2026.116149
|
| 20 |
Wen-Jun Zhang, Ji-Peng Liu, Yong-Sheng Xu, Cheng Zuo, Jun-Xiang Liao, Fu-Qi Zhu, Jia-Ling Hu. Olfactory ensheathing cell transplantation alleviates cancer pain by inhibiting P2X7 receptor expression–mediated activation of microglia. International Journal of Surgery 2025; 111(11) doi: 10.1097/JS9.0000000000002976
|
| 21 |
Wen-jun Zhang, Chen Luo, Fan-qin Pu, Jing-feng Zhu, Zhengming Zhu. The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain. Pharmacological Research 2020; 161 doi: 10.1016/j.phrs.2020.105106
|
| 22 |
Wen‐jun Zhang, Chang‐lei Wu, Ji‐peng Liu. Schwann cells as a target cell for the treatment of cancer pain. Glia 2023; 71(10) doi: 10.1002/glia.24391
|
| 23 |
Manju Tewari, Pankaj Seth. Emerging role of P2X7 receptors in CNS health and disease. Ageing Research Reviews 2015; 24 doi: 10.1016/j.arr.2015.10.001
|
| 24 |
Yinghao Wang, Zhihuang Chen, Chen Liu, Xuehua Lu, Ce Yang, Songping Qiu. Distributive differences of P2Xs between the forelimb and hind limb of adjuvant arthritis rats and intervention by Notopterygh rhizoma et radix. Pharmaceutical Biology 2019; 57(1) doi: 10.1080/13880209.2018.1561730
|
| 25 |
Yucui Jiang, Fan Ye, Ying Du, Yingxin Zong, Zongxiang Tang. P2X7R in Mast Cells is a Potential Target for Salicylic Acid and Aspirin in Treatment of Inflammatory Pain. Journal of Inflammation Research 2021; doi: 10.2147/JIR.S313348
|
| 26 |
Yong-Juan Gu, He-Ya Qian, Fang Zhou, Ling Zhang, Long Chen, Yu Song, Ya-Nan Chen, Hai-Long Zhang. Folic acid relieves bone cancer pain by downregulating P2X2/3 receptors in rats. Brain Research 2023; 1811 doi: 10.1016/j.brainres.2023.148405
|
| 27 |
Victoria Monge-Fuentes, Claudia Arenas, Priscilla Galante, Jacqueline Coimbra Gonçalves, Márcia Renata Mortari, Elisabeth Ferroni Schwartz. Arthropod toxins and their antinociceptive properties: From venoms to painkillers. Pharmacology & Therapeutics 2018; 188 doi: 10.1016/j.pharmthera.2018.03.007
|
| 28 |
Wen-jun Zhang, Zheng-ming Zhu, Zeng-xu Liu. The role and pharmacological properties of the P2X7 receptor in neuropathic pain. Brain Research Bulletin 2020; 155 doi: 10.1016/j.brainresbull.2019.11.006
|
| 29 |
Elena De Marchi, Elisa Orioli, Diego Dal Ben, Elena Adinolfi. Ion channels as therapeutic targets, part B. Advances in Protein Chemistry and Structural Biology 2016; 104 doi: 10.1016/bs.apcsb.2015.11.004
|
| 30 |
Katharina Sophie Erlitz, Ann-Kathrin Prinz, Stefan Wagner, Joana Massa, Calvin Dunker, Meike Höhl, Angelika Griep, Róisín M. McManus, Sonja Schelhaas, Oliver Koch, Anna Junker. Naphtho[1,2-b][1,4]diazepinedione-Based P2X4 Receptor Antagonists from Structure–Activity Relationship Studies toward PET Tracer Development. Journal of Medicinal Chemistry 2025; 68(7) doi: 10.1021/acs.jmedchem.4c02171
|
| 31 |
Francisco Reyes‐Espinosa, María G. Nieto‐Pescador, Virgilio Bocanegra‐García, Eduardo Lozano‐Guzmán, Gildardo Rivera. In Silico Analysis of FDA Drugs as P2X4 Modulators for the Treatment of Alcohol Use Disorder. Molecular Informatics 2020; 39(9) doi: 10.1002/minf.201900111
|
| 32 |
Ruofan Zhang, Yachen Yang, Xiang Li, Chunmeng Jiao, Mengping Lou, Wenli Mi, Qi-Liang Mao-Ying, Yuxia Chu, Yanqing Wang. Exploring shared targets in cancer immunotherapy and cancer-induced bone pain: Insights from preclinical studies. Cancer Letters 2025; 611 doi: 10.1016/j.canlet.2024.217399
|
| 33 |
Margarete Dulce Bagatini, Alessandra Antunes dos Santos, Andréia Machado Cardoso, Aline Mânica, Cristina Ruedell Reschke, Fabiano Barbosa Carvalho. The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases. Journal of Immunology Research 2018; 2018 doi: 10.1155/2018/4892473
|
| 34 |
Chenyu Chang, Xutao Wu, Kejia Liu, Lei Wang, Mozili Adu, Qingyuan Lin, Huilian Huang, Qinge Ma, Rongrui Wei, Xiaoyun Wang, Wenmin Liu. A comprehensive review on pain: Model, target, therapy, and prospect (Review). International Journal of Molecular Medicine 2025; 57(2) doi: 10.3892/ijmm.2025.5717
|